Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Which patients with hepatitis C develop liver complications?

M H Khan1, G C Farrell, K Byth

  • 1Storr Liver Unit, University of Sydney at Westmead Hospital, Australia.

Hepatology (Baltimore, Md.)
|February 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Education:</i> A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR <i>Pseudomonas aeruginosa</i>.

JAC-antimicrobial resistance·2021
Same author

A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.

Alimentary pharmacology & therapeutics·2018
Same author

Incomplete Kawasaki Disease with coronary aneurysms in a young infant of 45 days presented as neonatal sepsis

The Ceylon medical journal·2018
Same author

Causes and mechanisms of adipocyte enlargement and adipose expansion.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2017
Same author

Week 4 viral load predicts long-term suppression of hepatitis B virus DNA during antiviral therapy: improving hepatitis B treatment in the real world.

Internal medicine journal·2016
Same author

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.

Genes and immunity·2016

Advanced fibrosis and low albumin levels are key predictors of liver complications in chronic hepatitis C patients. Sporadic transmission also increases risk for liver disease and hepatocellular carcinoma (HCC).

Area of Science:

  • Hepatology
  • Virology
  • Clinical Medicine

Background:

  • Chronic hepatitis C virus (HCV) infection can lead to severe liver complications.
  • Identifying predictors of adverse outcomes is crucial for patient management.

Purpose of the Study:

  • To identify independent predictors of liver complications, hepatocellular carcinoma (HCC), and liver-related death in chronic hepatitis C patients.

Main Methods:

  • A cohort of 455 patients with chronic hepatitis C was followed for a median of 4.7 years.
  • Multivariate analysis was used to identify independent predictors of adverse outcomes.
  • Demographic, behavioral, viral, histological, and biochemical factors were analyzed.

Main Results:

  • Advanced fibrosis (cirrhosis), sporadic transmission, and low serum albumin were independent predictors of liver-related complications.

Related Experiment Videos

  • Male gender, sporadic transmission, and low albumin predicted HCC.
  • Elevated bilirubin predicted liver transplantation or liver-related death.

    • Conclusions:

    • Only patients with advanced hepatic fibrosis or cirrhosis are at significant risk of complications within a 5-year follow-up.
    • Abnormalities in albumin, bilirubin, or prothrombin time in these patients indicate a high probability of complications.
    • Sporadic transmission cases may have higher risk due to interactions between age, infection duration, origin, and HCV genotype.